Other News To Note
Tuesday, May 22, 2012
BioDelivery Sciences International Inc., of Raleigh, N.C., received a milestone payment of $2.5 million from Meda AB, of Goteborg, Sweden, for registration and pricing approval of Breakyl (Onsolis). It will be eligible for a final milestone payment of $2.5 million upon commercial launch, which is anticipated in late 2012.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.